P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
Status:
RECRUITING
Trial end date:
2027-10-04
Target enrollment:
Participant gender:
Summary
Primary: To evaluate the efficacy of CTN in adults ages with ADHD and comorbid anxiety (AISRS) Key Secondary: To assess the efficacy of CTN in adults ages with ADHD and comorbid anxiety
Phase:
PHASE3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.